載入...
From Pure Antagonists to Pure Degraders of the Estrogen Receptor: Evolving Strategies for the Same Target
[Image: see text] Pure antiestrogens, or selective estrogen receptor degraders (SERDs), have proven to be effective in treating breast cancer that has progressed on tamoxifen and/or aromatase inhibitors. However, the only FDA-approved pure antiestrogen, fulvestrant, is limited in efficacy by its low...
Na minha lista:
| 發表在: | ACS Omega |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Chemical Society
2021
|
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8047716/ https://ncbi.nlm.nih.gov/pubmed/33869913 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.0c06362 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|